REDHILL BIOPHARMA LTD. Losses On Change In Fair Value Of Derivatives
REDHILL BIOPHARMA LTD. (RDHL) reported Losses On Change In Fair Value Of Derivatives of $5.57 million for the 12-month period ending 2023-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:LossesOnChangeInFairValueOfDerivatives · last filed 2025-04-10
| Period end | Losses On Change In Fair Value Of Derivatives 12 month |
|---|---|
| 2023-12-31 | $5.57M 20-F · filed 2025-04-10 |